Trade Mark Journal No.2025/047 21 November 2025

WO0000001885489 (5)

Office of origin: United States of America

Date of International Registration:13 October 2025
Date of designation in the UK: 13 October 2025
Image for mark 1885489 AQVESME

International priority date claimed: 22 August 2025 (United States of America) (99351679)
Class 5
Pharmaceutical preparations for the treatment of blood disorders, hemolytic anemia and diseases effecting red blood cells.

Agios Pharmaceuticals, Inc.

Representative: Maury M. Tepper, III Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609, UNITED STATES OF AMERICA